Research design considerations for chronic pain prevention clinical trialsJennifer S. Gewandter, Gary A. Walco, Roger B. Fillingim et al.|Pain|2015Cited by 143
Firategrast for relapsing remitting multiple sclerosis: a phase 2, randomised, double-blind, placebo-controlled trialDavid H. Miller, Xavier Montalbán, Thomas Weber et al.|The Lancet Neurology|2012Cited by 77